Association between serum PCSK9 and coronary heart disease in patients with type 2 diabetes mellitus

被引：0
|
作者：
Juan Huang
Jun-Xu Gu
Kun Wang
Ai-Min Zhang
Ting-Ting Hong
Shan-Shan Li
Xiao-Qin Yao
Ming Yang
Yue Yin
Na Zhang
Ming Su
Jia-Jia Hu
Xue-Zhi Zhang
Mei Jia
机构：
[1] Peking University International Hospital,Department of traditional Chinese medicine
[2] Peking University People’s Hospital,Department of Clinical Laboratory
[3] Central South University,Department of Clinical Laboratory, Xiangya Hospital
[4] Peking University International Hospital,Department of Clinical Laboratory
来源：
Diabetology & Metabolic Syndrome | / 15卷
关键词：
PCSK9; T2DM; Coronary heart disease; Cardiovascular events;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Association between serum PCSK9 and coronary heart disease in patients with type 2 diabetes mellitus
    Huang, Juan
    Gu, Jun-Xu
    Wang, Kun
    Zhang, Ai-Min
    Hong, Ting-Ting
    Li, Shan-Shan
    Yao, Xiao-Qin
    Yang, Ming
    Yin, Yue
    Zhang, Na
    Su, Ming
    Hu, Jia-Jia
    Zhang, Xue-Zhi
    Jia, Mei
    DIABETOLOGY & METABOLIC SYNDROME, 2023, 15 (01):
  • [2] The association between circulatory, local pancreatic PCSK9 and type 2 diabetes mellitus: The effects of antidiabetic drugs on PCSK9
    Lu, Fengyuan
    Li, En
    Yang, Xiaoyu
    HELIYON, 2023, 9 (09)
  • [3] ASSOCIATION OF APOLIPOPROTEINS PLASMA LEVELS WITH PCSK9 IN TYPE 2 DIABETES MELLITUS
    Baudin, Bruno
    Nekaies, Ymene
    Baudin, Bruno
    Kelbousi, Sami
    Sakly, Mohsen
    Attia, Nebil
    ATHEROSCLEROSIS, 2017, 263 : E273 - E274
  • [4] The association between serum Sestrin2 and the risk of coronary heart disease in patients with type 2 diabetes mellitus
    Xue Tian
    Yu Gao
    Min Zhong
    Mowei Kong
    Lihua Zhao
    Zengbin Feng
    Qitian Sun
    Jianqiu He
    Xiaoyan Liu
    BMC Cardiovascular Disorders, 22
  • [5] The association between serum Sestrin2 and the risk of coronary heart disease in patients with type 2 diabetes mellitus
    Tian, Xue
    Gao, Yu
    Zhong, Min
    Kong, Mowei
    Zhao, Lihua
    Feng, Zengbin
    Sun, Qitian
    He, Jianqiu
    Liu, Xiaoyan
    BMC CARDIOVASCULAR DISORDERS, 2022, 22 (01)
  • [6] NO ASSOCIATION BETWEEN CHANGES IN LIPID PARAMETERS AND TOTAL PCSK9 IN CORONARY ARTERY DISEASE PATIENTS TREATED WITH PCSK9 INHIBITORS
    Ugovsek, S.
    Likozar, A. Rehberger
    Sebestjen, M.
    ATHEROSCLEROSIS, 2023, 379 : S173 - S173
  • [7] Increased serum PCSK9 levels are associated with renal function impairment in patients with type 2 diabetes mellitus
    Feng, Zhicai
    Liao, Xiangyu
    Zhang, Hao
    Peng, Juan
    Huang, Zhijun
    Yi, Bin
    RENAL FAILURE, 2023, 45 (01)
  • [8] Correlation between serum Galanin,Leptin and coronary heart disease in patients with type 2 diabetes mellitus
    李敏
    China Medical Abstracts (Internal Medicine), 2023, 40 (01) : 23 - 24
  • [9] PCSK9 inhibition and type 2 diabetes
    Lotta, Luca A.
    Griffin, Simon J.
    LANCET DIABETES & ENDOCRINOLOGY, 2017, 5 (12): : 926 - 927
  • [10] CORRELATION BETWEEN PCSK9 AND LEVEL OF INFLAMMATION IN ATHEROSCLEROTIC PLAQUES IN PATIENTS WITH CORONARY HEART DISEASE
    Mohammed, Esam. L. Q.
    Shi, Guangyao
    Yu, Shujie
    Liu, Yong
    Qian, Xiaoxian
    JOURNAL OF HYPERTENSION, 2018, 36 : E182 - E182
12345